Biozeus

Biozeus is a clinical-stage biotech company that transforms academic discoveries into innovative therapies. We advance promising compounds from preclinical to clinical development, bridging the gap between early-stage research and the market. Founded in 2012 and backed by Brazilian venture capital, Biozeus combines scientific expertise and strategic management to identify, in-license, and develop high-potential drug candidates. Through a disciplined Go/No-Go decision process, only projects with strong scientific and commercial potential move forward to pivotal clinical stages.